+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market - Global Forecast 2025-2030- Product Image
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market - Global Forecast 2025-2030- Product Image
Sale

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6139725
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Gene mutation detection kits, now integral to precision oncology, are transforming clinical decision-making and patient outcomes by enabling targeted therapy selection, monitoring treatment efficacy, and detecting emerging resistance. Market growth is accelerating as new technologies, regulatory changes, and evolving reimbursement models converge to increase adoption in both specialized centers and community healthcare settings.

Market Snapshot: Gene Mutation Detection Kit Market Overview

The gene mutation detection kit market continues to evolve rapidly, shaped by strong demand for precision oncology solutions. Increased integration of advanced diagnostic methods—including digital PCR, next-generation sequencing (NGS), and real-time PCR—is streamlining laboratory workflows and supporting timely, accurate clinical decisions. Market expansion is bolstered by innovations in multiplexed panels that conserve samples while providing comprehensive mutation profiles. Meanwhile, global regulatory bodies are instituting higher standards, driving the adoption of validated, quality-controlled assays that meet clinician and patient expectations for reliability. Growth is further supported by the gradual alignment of reimbursement structures with demonstrated clinical value, incentivizing hospitals, diagnostic labs, and research institutions to invest in cutting-edge detection platforms.

Scope & Segmentation: Coverage of the Gene Mutation Detection Kit Market

  • Technology: Digital PCR, Next Generation Sequencing, Real Time PCR, Sanger Sequencing
  • Sequencing Methods: Targeted Sequencing, Whole Exome Sequencing, Whole Genome Sequencing
  • Cancer Types: Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma
  • End Users: Academic and Research Institutes, Diagnostic Laboratories, Hospitals and Clinics
  • Sample Types: Blood Plasma, Tissue
  • Product Types: Instruments, Reagent Kits
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Switzerland, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies Profiled: Roche Holding AG, Thermo Fisher Scientific, QIAGEN, Illumina, Agilent Technologies, Bio-Rad Laboratories, Abbott Laboratories, bioMérieux, Sysmex Corporation, Amoy Diagnostics

Primary Keyword: gene mutation detection kit

Key Takeaways for Decision-Makers

  • Rapid advances in digital PCR and NGS have substantially improved sensitivity and diagnostic accuracy, supporting personalized oncology across diverse clinical environments.
  • Assays now detect a broader range of genetic alterations, including point mutations, gene fusions, and copy number variations in pivotal genes such as EGFR, KRAS, BRAF, ALK, and ROS1.
  • Integration of AI-driven analytics with genomic data streamlines mutation classification and enables faster translation of results into actionable clinical decisions.
  • New collaborative commercialization models, including early access programs and companion diagnostics, foster agility and expand the market reach of leading assay developers.
  • Flexible reagent kits and scalable instrument platforms accommodate varied end-user needs, from high-throughput labs to specialized oncology centers.
  • Liquid biopsy adoption is enabling non-invasive longitudinal monitoring of tumor genetics, particularly using circulating tumor DNA from blood plasma for tracking disease progression and treatment response.

Tariff Impact: Economic and Regulatory Shifts in 2025

Recent United States tariffs on gene mutation detection kit imports have introduced cost pressures throughout global supply chains. Organizations are responding by diversifying manufacturing locations, investing in regional production hubs, and building stronger relationships with domestic suppliers to mitigate risk. Renegotiation of supply contracts and inventory management strategies are being adjusted to ensure assay availability. Market participants that adapt quickly to these changes—optimizing operations and logistics—are more likely to sustain innovation and margin performance in an evolving economic environment.

Methodology & Data Sources

This research integrates thorough secondary analysis of peer-reviewed medical literature, regulatory filings, and patent data with primary interviews of laboratory directors, clinical oncologists, payers, and research scientists. Multi-source data triangulation ensures the reliability of findings. Ongoing peer review and senior analyst oversight maintain quality and validity throughout the reporting process.

Why This Report Matters

  • Enables informed capital allocation by revealing technology trends and actionable segmentation insights across global regions.
  • Supports strategic planning to anticipate regulatory and economic headwinds, including the impact of tariffs and evolving reimbursement models.
  • Offers a roadmap for building effective collaborations with academic researchers, industry partners, and clinicians, accelerating market adoption and clinical standardization.

Conclusion

Strategic investments in gene mutation detection kits are redefining oncology diagnostics, driving innovation and alignment with precision medicine objectives. Forward-thinking leaders are prioritizing technology integration and regulatory adaptability to sustain growth and clinical impact in this dynamic market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growth of liquid biopsy adoption driving demand for ultra-sensitive EGFR KRAS BRAF PIK3CA ALK ROS1 mutation detection kits
5.2. Integration of next-generation sequencing and digital PCR to enhance multiplex gene mutation profiling in precision oncology
5.3. Increasing regulatory approvals of companion diagnostics for targeted lung cancer therapies boosting clinical adoption of mutation detection kits
5.4. Strategic collaborations between diagnostic manufacturers and oncology research centers accelerating biomarker validation for early mutation profiling
5.5. Shift toward decentralized testing with portable point-of-care platforms enabling rapid EGFR KRAS ALK ROS1 mutation screening in clinical settings
5.6. Integration of artificial intelligence for automated analysis of EGFR KRAS BRAF PIK3CA ALK ROS1 test results improving laboratory workflow efficiency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Technology
8.1. Introduction
8.2. Digital Pcr
8.3. Next Gen Sequencing
8.3.1. Targeted Sequencing
8.3.2. Whole Exome Sequencing
8.3.3. Whole Genome Sequencing
8.4. Real Time Pcr
8.5. Sanger Sequencing
9. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Cancer Type
9.1. Introduction
9.2. Breast Cancer
9.3. Colorectal Cancer
9.4. Lung Cancer
9.5. Melanoma
10. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Diagnostic Laboratories
10.4. Hospitals And Clinics
11. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Sample Type
11.1. Introduction
11.2. Blood Plasma
11.3. Tissue
12. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Product Type
12.1. Introduction
12.2. Instruments
12.3. Reagent Kits
13. Americas Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Roche Holding AG
16.3.2. Thermo Fisher Scientific, Inc.
16.3.3. QIAGEN N.V.
16.3.4. Illumina, Inc.
16.3.5. Agilent Technologies, Inc.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Abbott Laboratories, Inc.
16.3.8. bioMérieux SA
16.3.9. Sysmex Corporation
16.3.10. Amoy Diagnostics Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET: RESEARCHAI
FIGURE 26. HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET: RESEARCHSTATISTICS
FIGURE 27. HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET: RESEARCHCONTACTS
FIGURE 28. HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY BLOOD PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY BLOOD PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENT KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENT KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 88. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 89. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. CANADA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 100. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 101. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 162. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 163. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 165. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 168. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 169. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. GERMANY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 174. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 175. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 177. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 180. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 181. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. FRANCE HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 198. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 199. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 200. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 201. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 204. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 205. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. ITALY HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 210. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 211. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 213. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. SPAIN HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA HUMAN EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 GENE MUTATION DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA HUMAN EGFR/KRAS/BRAF/

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market report include:
  • Roche Holding AG
  • Thermo Fisher Scientific, Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories, Inc.
  • bioMérieux SA
  • Sysmex Corporation
  • Amoy Diagnostics Co., Ltd.

Related Topics

Related Reports

Human EGFR Gene Mutation Detection Kit Market - Global Forecast 2025-2030 - Product Image

Human EGFR Gene Mutation Detection Kit Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
EGFR Tests Market - Global Forecast 2025-2030 - Product Image

EGFR Tests Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • Global
From
Japan Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others - Product Image

Japan Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • Report
  • 150 Pages
  • Japan
From
Companion Diagnostics Market Report and Forecast 2025-2034 - Product Image

Companion Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.